✨ Medicines Consent Notices
1768
NEW ZEALAND GAZETTE
No. 67
Product: Ceftriaxone Sodium for Injection
Active Ingredient: Ceftriaxone sodium 298.25mg equivalent to Ceftriaxone 250mg
Dosage Form: Powder for injection
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Anfarm Hellas SA, Schimatari, Greece
Product: Ceftriaxone Sodium for Injection
Active Ingredient: Ceftriaxone sodium 596.5mg equivalent to Ceftriaxone 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Anfarm Hellas SA, Schimatari, Greece
Product: Ceftriaxone
Active Ingredient: Ceftriaxone sodium 1,079.3mg equivalent to 1000mg anhydrous ceftriaxone
Dosage Form: Powder for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Hikma Farmaceutica (Portugal) Lda, Fervenca, Terrugem – Sintra, Portugal
Product: Ceftriaxone
Active Ingredient: Ceftriaxone sodium 2,158.6mg equivalent to 2000mg anhydrous ceftriaxone
Dosage Form: Powder for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Hikma Farmaceutica (Portugal) Lda, Fervenca, Terrugem – Sintra, Portugal
Product: Ceftriaxone
Active Ingredient: Ceftriaxone sodium 269.9mg equivalent to 250mg anhydrous ceftriaxone
Dosage Form: Powder for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Hikma Farmaceutica (Portugal) Lda, Fervenca, Terrugem – Sintra, Portugal
Product: Ceftriaxone
Active Ingredient: Ceftriaxone sodium 539.7mg equivalent to 500mg anhydrous ceftriaxone
Dosage Form: Powder for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Hikma Farmaceutica (Portugal) Lda, Fervenca, Terrugem – Sintra, Portugal
Product: Implanon
Active Ingredient: Etonogestrel 68mg
Dosage Form: Subcutaneous implant
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: Organon International BV, Oss, The Netherlands
Product: i-Profen
Active Ingredient: Ibuprofen 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Dated this 12th day of June 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go4024
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Somac
Active Ingredient: Pantoprazole sodium 22.57mg equivalent to 20 mg Pantoprazole
Dosage Form: Enteric coated tablet
New Zealand Sponsor: Pharmacia Limited Company trading as Pharmacia
Manufacturers: Byk Gulden Lomberg Chemische Fabrik GmbH, Konstanz, Germany
Oranienburger Pharmawerk GmbH, Oranienburg, Germany
Dated this 12th day of June 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go4023
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 67
Gazette.govt.nz —
NZ Gazette 2002, No 67
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare12 June 2002
Medicines, Consent, Distribution, Health, Ceftriaxone, Implanon, i-Profen
- G. R. Boyd, Chief Advisor, Safety and Regulation
🏥 Consent to the Distribution of a Changed Medicine
🏥 Health & Social Welfare12 June 2002
Medicines, Consent, Distribution, Health, Somac
- G. R. Boyd, Chief Advisor, Safety and Regulation